Inspire Medical Systems (INSP) Price & Analysis

Compare

800 Followers

INSP Stock Chart & Stats

$73.45

-$1.46(-0.68%)

At close: Jan 08 4:00 PM EST

$73.45

-$1.46(-0.68%)

Day’s Range― - ―

52-Week Range$70.77 - $203.12

Previous CloseN/A

Volume95.34K

Average Volume (3M)1.08M

Market Cap

$2.20B

Enterprise Value$2.16B

Total Cash (Recent Filing)$322.59M

Total Debt (Recent Filing)$32.58M

Price to Earnings (P/E)50.4

Beta0.38

Next Earnings

Feb 11, 2026

EPS Estimate

0.68

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.38

Shares Outstanding29,056,435

10 Day Avg. Volume1,446,050

30 Day Avg. Volume1,084,064

Financial Highlights & Ratios

PEG Ratio-0.29

Price to Book (P/B)8.00

Price to Sales (P/S)6.87

P/FCF Ratio60.55

Enterprise Value/Market Cap0.98

Enterprise Value/Revenue2.45

Enterprise Value/Gross Profit2.88

Enterprise Value/Ebitda28.20

Forecast

1Y Price Target

$137.62

Price Target Upside87.37% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering18

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Patient Acquisition And VolumeIncreased advertising spend coupled with the planned conversion of patient warehousing into a 2026 tailwind is expected to expand patient throughput and sustain procedure volume growth.

Pricing PowerPlanned material price increases are expected to boost revenue per procedure and contribute meaningfully to top-line growth if implemented as anticipated.

Reimbursement RecognitionCMS upcoding of the hypoglossal nerve stimulation procedure to a higher payment level signals formal recognition of the procedure's resource intensity, supporting stronger facility reimbursement per case.

Bears Say

Competition And Adoption HeadwindsRising competition, physician concerns about GLP-1 impacts, lower doctor fee reimbursement, and execution delays in rollout could slow surgeon adoption and limit volume acceleration.

Medicare Administrative Contractor ActionsRemovals of CPT code 64568 by certain MACs have already weighed on the stock and raise the risk that further MAC pullbacks could erode an expected pricing tailwind.

Regional Coverage FragmentationDelegation of coverage decisions to regional Medicare contractors creates inconsistent reimbursement policies across regions, increasing uncertainty about future payment outcomes.

Inspire Medical Systems News

Inspire Medical downgraded to Sector Perform from Outperform at RBC Capital

RBC Capital downgraded Inspire Medical (INSP) to Sector Perform from Outperform with a price target of $90, down...

8d ago

INSP

Truist downgrades Inspire Medical as coding uncertainty takes upside off table

As previously reported, Truist downgraded Inspire Medical (INSP) to Hold from Buy with a price target of $96,...

12d ago

INSP

Inspire Medical downgraded to Hold from Buy at Truist

Truist analyst Richard Newitter downgraded Inspire Medical (INSP) to Hold from Buy with a $96 price target Published...

12d ago

INSP

Inspire Medical drops as CMS correction triggers Oppenheimer downgrade

Shares of Inspire Medical (INSP) are under performing on Thursday after the Centers for Medicare & Medicaid Services...

12d ago

INSP

Evercore ISI says Inspire Medical guide should be intact despite CMS correction

Evercore ISI analyst Daniel Markowitz notes that the Centers for Medicare & Medicaid Services has issued an update...

12d ago

INSP

Inspire Medical downgraded at Oppenheimer after CMS issues correction

As previously reported, Oppenheimer downgraded Inspire Medical (INSP) to Perform from Outperform and removed the firm’s price target...

12d ago

INSP

Inspire Medical downgraded to Perform from Outperform at Oppenheimer

Oppenheimer downgraded Inspire Medical (INSP) to Perform from Outperform. Published first on TheFly – the ultimate source for...

12d ago

INSP

Inspire Medical price target lowered to $145 from $160 at Wells Fargo

Wells Fargo lowered the firm’s price target on Inspire Medical (INSP) to $145 from $160 and keeps an...

20d ago

INSP

Inspire Medical names Matt Osberg as new CFO

The company also announced the appointment of Matt Osberg as its new Executive Vice President and CFO. Osberg...

22d ago

INSP

Inspire Medical sees Q4 revenue $268.9M-$269.1M, consensus $262.3M

An approximately 12% increase over the same quarter of 2024. “We are very pleased with our strong preliminary...

22d ago

INSP

Inspire Medical Systems Issues Strong Preliminary 2025 Revenue Results

Inspire Medical Systems ( ($INSP) ) has issued an announcement. On January 12, 2026, Inspire Medical Systems reported...

22d ago

INSP

Inspire Medical Systems (INSP) Facing Lawsuit Over Sleep Apnea Treatment Claims

A class action lawsuit was filed against Inspire Medical Systems ($INSP) on November 6, 2025. Plaintiffs in the...

1M ago

INSP

Inspire Medical Systems: Temporary MAC-CMS Reimbursement Misalignment Creates Overdone Pullback, Supporting Continued Buy Rating

In a report released today, Richard Newitter from Truist Financial maintained a Buy rating on Inspire Medical Systems,...

2M ago

INSP

Inspire Medical Systems: Balancing Positive Reimbursement Developments with Market Uncertainties

Analyst Richard Newitter from Truist Financial maintained a Hold rating on Inspire Medical Systems and increased the price...

2M ago

INSP

INSP FAQ

What was Inspire Medical Systems’s price range in the past 12 months?

Inspire Medical Systems lowest stock price was $70.77 and its highest was $203.12 in the past 12 months.

What is Inspire Medical Systems’s market cap?

Inspire Medical Systems’s market cap is $2.20B.

When is Inspire Medical Systems’s upcoming earnings report date?

Inspire Medical Systems’s upcoming earnings report date is Feb 11, 2026 which is in 8 days.

How were Inspire Medical Systems’s earnings last quarter?

Inspire Medical Systems released its earnings results on Nov 03, 2025. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of -$0.189 by $0.569.

Is Inspire Medical Systems overvalued?

According to Wall Street analysts Inspire Medical Systems’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Inspire Medical Systems pay dividends?

Inspire Medical Systems does not currently pay dividends.

What is Inspire Medical Systems’s EPS estimate?

Inspire Medical Systems’s EPS estimate is 0.68.

How many shares outstanding does Inspire Medical Systems have?

Inspire Medical Systems has 29,056,435 shares outstanding.

What happened to Inspire Medical Systems’s price movement after its last earnings report?

Inspire Medical Systems reported an EPS of $0.38 in its last earnings report, beating expectations of -$0.189. Following the earnings report the stock price went up 15.33%.

Which hedge fund is a major shareholder of Inspire Medical Systems?

Currently, no hedge funds are holding shares in INSP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Inspire Medical Systems Stock Smart Score

Neutral

Fundamentals

Return on Equity

6.54%

Trailing 12-Months

Asset Growth

1.45%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Inspire Medical Systems

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems (INSP) Earnings & Revenues

Historic Earnings Reports

INSP Company Deck

INSP Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call highlighted strong revenue growth and improved gross margins, driven by the successful launch and adoption of Inspire V and positive clinical outcomes. However, these positives were somewhat offset by increased operating expenses and decreased net income compared to the prior year. The company remains optimistic with increased earnings guidance and improved reimbursement outlook.View all INSP earnings summaries

INSP Revenue Breakdown

97.02% U.S.

2.98% Other

INSP Stock 12 Month Forecast

Average Price Target

$137.62

▲(87.37% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"71":"$71","194":"$194","101.75":"$101.8","132.5":"$132.5","163.25":"$163.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":180,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$180.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":137.62,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$137.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[71,101.75,132.5,163.25,194],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,81.64615384615385,89.8423076923077,98.03846153846155,106.23461538461538,114.43076923076924,122.62692307692308,130.82307692307694,139.01923076923077,147.2153846153846,155.41153846153847,163.60769230769233,171.80384615384617,{"y":180,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,78.38615384615385,83.3223076923077,88.25846153846155,93.19461538461539,98.13076923076923,103.06692307692308,108.00307692307693,112.93923076923078,117.87538461538462,122.81153846153848,127.74769230769232,132.68384615384616,{"y":137.62,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,73.45,74.72307692307693,75.99615384615385,77.26923076923077,78.54230769230769,79.81538461538462,81.08846153846154,82.36153846153846,83.63461538461539,84.90769230769232,86.18076923076923,87.45384615384616,88.72692307692307,{"y":90,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":193.5,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157.98,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":157.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":133.73,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":130.81,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.1,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.51,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.38,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.08,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":126.34,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 47,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.23,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 58,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 39, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.45,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >